FY26: A Tariff Refund Flatters an Unfinished Reset

Thesis status: Affirmed in structure. Flattered by a refund. Still correcting underneath.

Thesis Refresher

The marketplace correction primer argued that Nike ($NKE) is correcting, not collapsing: that the direct-to-consumer overreach of FY2022-23 strained the marketplace and compressed margins without permanently impairing pricing power or consumer preference. The test is whether the reset under Elliott Hill restores compounding before structural damage sets in. The horizon runs 24 to 36 months.

This is the second update to that primer. The first, at the third quarter, affirmed the correction in North America and separated Greater China into its own recovery frame. FY2026, reported 30 June 2026, is the first full-year read against the thesis. It carries a quantitative treatment the primer did not. The share price has fallen to roughly $41 from about $72 a year earlier, and a reverse-DCF now frames what that price embeds. The fiscal 2026 Form 10-K follows in late July and will complete the cash-flow and risk-factor picture.

FY2026 in Brief

The full-year print reads like stabilisation. Revenue held flat, gross margin expanded, and fourth-quarter net income rose more than fourfold. Each of those figures rests on one accrual. Nike recognised the recovery of tariffs it had already paid under the International Emergency Economic Powers Act once the claim became probable in the fourth quarter, which added $986M to gross profit and $0.52 to fourth-quarter EPS. Without it, the year that looks like a turn was a further step down.

The $986M That Flatters the Print

The benefit is a refund, not an operating gain. Nike booked it to cost of sales, reversing tariffs previously expensed when the recovery of the IEEPA claims became probable. On the underlying line the picture inverts.

Operational gross margin fell 190 basis points to 40.8%, and underlying EBIT margin dropped to roughly 6.2%, below the 8.2% Nike reported for FY2025. The drivers were higher discounts and an unfavourable channel mix as wholesale grew against digital declines, higher obsolescence reserves concentrated in Greater China, and close to $400M of pre-tax severance to reposition the organisation under the Sport Offense operating model. The business the primer described as correcting is, on an operating basis, still contracting.

Only about $300M of the $986M arrived as cash in FY2026. The remaining $686M sits as a receivable at 31 May 2026 and accounts for more than half of the rise in accounts receivable to $5.9B from $4.7B. Management guided the gross margin to inflect back to expansion in the first quarter of FY2027, pulled forward from the second quarter it guided three months earlier. The refund cleared the headline. The operating recovery it stands in for has not yet arrived.

What the Price Implies

This section characterises what the current share price requires in operating terms. It is not a valuation or a price target. The watch conditions test whether the business is navigating toward what the price embeds.

The base is FY2026 stripped of the refund. Normalised EBIT of $2,864M against $46.4B of revenue is a 6.2% margin, the operating trough. Against an enterprise value of $59.7B, the question is how far that margin has to climb to support the price.

At a 9.1% discount rate and 3% revenue growth, the price implies a terminal EBIT margin of about 10.5%, most of the way back to the 12% Nike earned before the correction. The figure moves with the growth assumption. Hold revenue near the flat trajectory of FY2026 and the price requires close to 12.7%, a full return to the prior peak. Assume a genuine re-acceleration to 5% and it eases to 8.7%. The price asks for a margin recovery, a revenue recovery, or a combination of the two. It does not clear on the current operating trajectory.

The risk around that embedded recovery is asymmetric. A full return to 12% supports about $46, roughly 12% above the current price. A margin that recovers only as far as the tariffs lapsing, back to the 8.2% of FY2025, supports about $34. A margin that stays at the 6.2% underlying trough supports about $27. The price sits near the upper end of that range.

That base carries a qualifier the reverse-DCF should not bury. The $986M refund largely offsets the IEEPA tariffs Nike recognised during FY2026, so the 6.2% underlying still absorbs the full cost of a tariff regime the Supreme Court struck down in February. Nike now operates under the different, and apparently lower, Section 122 baseline. Part of the climb from 6.2% is mechanical, the invalidated regime rolling off rather than operating leverage being earned. On the grid above, that roll-off alone carries the margin toward the 8.2% of FY2025 and a value near $34. The step from there to the $41 price is the operating leverage Nike has to earn, and it is a smaller climb than the raw gap from the trough implies. The market is pricing a recovery. How much of it Nike earns, and how much the tariff arithmetic returns as the old regime lapses, is the distinction the next several quarters resolve.

The embedded recovery rests on the load-bearing conditions. The table maps where a failure truncates the margin path the price assumes.

The price implies none of these bite within the horizon.

Watch Condition Assessment

Key. C marks a confirming signal, W a warning. Tier is the thesis's dependence: a load-bearing failure breaks the case, an amplifying one sets the scale. Status denotes thesis impact, not signal direction, so a warning that is not firing reads green. 🟢 Affirmed tracks at or ahead of what the thesis needs, 🟡 Developing is mixed, 🔴 Weakening tracks against it. Trend is movement since the Q3 memo: ↑ improved, → unchanged, ↓ deteriorated.

C1: Revenue stabilisation relative to cost structure

🟡 Developing → Cost discipline held, but the operating margin the condition tracks fell once the refund is removed.

Selling and administrative expense was flat at $16.1B against flat revenue, and operating overhead was flat at $11.4B while absorbing close to $400M of severance offset by lower administrative costs. The cost side is being managed to plan. The operating result is not. Underlying EBIT margin of 6.2%, stripped of the IEEPA benefit, sits below the 8.2% Nike reported for FY2025, because revenue held flat and gross margin compressed beneath the refund. Management guided the gross margin to inflect back to expansion in the first quarter of FY2027, pulled forward one quarter, and reiterated a trajectory back to double-digit margins. The condition requires modest top-line recovery alongside the expense discipline. The discipline is present. The leverage is not yet.

C2: Inventory health without markdown dependency

🟢 Affirmed → Inventory is clean and promotions were cut hard, with soft sell-through the one caution.

Total inventory of $7.5B was flat year-over-year, with units up and offset by product mix. North America inventory grew mid-single digits, which management described as in line with plans, while Greater China fell double digits. The markdown discipline the condition tracks strengthened. Nike reduced off-price digital sales in Europe by 50% and lifted EMEA full-price realisation by 1,500 bps. The caution sits on the demand side, where management stated sell-through remained challenged in the fourth quarter and EMEA continues to carry heightened inventory. The discipline holds. The demand that clears it is softer.

C3: Greater China trajectory

🔴 Weakening → Revenue kept falling in line with the Q3 boundary, and the gap with peers widened.

Greater China revenue declined 11% reported and 13% currency-neutral, with the fourth quarter down 17% currency-neutral. Segment EBIT of $1,278M fell roughly 20% but stayed positive, and management stated that profitability will bottom before sales. Under the framework modification from the Q3 memo, China is tracked on profitability rather than revenue, and the profitability line is holding. The revenue line is not, and the peer comparison sharpened.

Management framed the reset as multi-year, with locally designed and manufactured product arriving in holiday 2027. The condition, framed on revenue stabilisation, stays outside its boundary.

W1: Tariff escalation past the 10% baseline

🟡 Developing → The past tariffs became a refund, and the forward rate steps up to 15%.

The IEEPA recovery resolved the incremental tariffs Nike had already paid. Looking forward, management's outlook assumes incremental tariff rates of 10% through the end of July 2026, rising to 15% thereafter, and guided the first quarter of FY2027 as the last quarter of material year-over-year tariff pressure on gross margin. That easing is a comparison effect. FY2026 absorbed the heavier IEEPA-era cost, so the year-over-year drag fades even as the forward rate steps up to 15%. The warning tests for escalation that reopens the margin-recovery timeline. The rate is escalating, bounded, and carried in guidance. Nike is also reducing US-bound footwear sourced from China toward the high-single-digit range by the end of FY2026, which lowers the exposure the warning tracks.

C4: Wholesale health

🟢 Affirmed ↑ Wholesale grew, and the $FL relationship turned positive for the first time in four years.

Wholesale revenue reached $27.5B, up 6% reported and 4% currency-neutral, with North America leading. Management stated that Nike revenue and retail sales comp at Foot Locker were positive for the first time in four years. The Q3 memo flagged concentration risk in the Dick's Sporting Goods ($DKS) and Foot Locker combined entity as Nike's largest North American partner. The FY2026 read is that the relationship is growing, which converts the concentration from a risk into leverage while the partner performs.

C5: NIKE Direct returns to full price

🟡 Developing ↑ Digital revenue kept falling, and the full-price repositioning showed in the numbers.

NIKE Direct revenue declined 6% reported and 8% currency-neutral, with NIKE Brand Digital down 12% and NIKE-owned stores down 4%. The revenue decline is the deliberate cost of the reset. The full-price signal improved beneath it. Management pointed to a 50% reduction in off-price digital sales in Europe, a 1,500 bps gain in EMEA full-price realisation, and a recovery in full-price realisation on digital after more aggressive actions to reduce promotions. The condition requires NIKE Direct back to full-price platform economics. Promotional intensity is falling. The platform is not yet operating at full price at scale.

Thesis Standing

The correction holds where Nike controls the levers. North America is growing, wholesale is re-engaging with the largest partner now positive, and the markdown discipline that resets full-price economics shows in a 50% cut to European off-price. On the operational mechanics, the affirmed conditions describe a marketplace being repaired to plan. The reset is real.

What the reset has not yet produced is the operating recovery the price assumes. The margin the primer set as the test of correction against erosion sits at 6.2% underlying, below where it began the year, while the reverse-DCF frames a share price that embeds a return most of the way to 12%. That gap is the memo's central tension. The business is executing the repair where it has control. The price has moved ahead of the margin the repair has so far delivered.

Greater China stays on the separate frame the Q3 memo established. Revenue is not the near-term metric under that frame. Profitability is, and management guided it to bottom before sales. The condition remains weakening on its original revenue terms and is monitored on the modified profitability terms until the fiscal-year restatement formalises the split.

The single most important variable is whether the margin inflects in the first quarter of FY2027 as guided. Every affirmed condition in this memo describes the marketplace being repaired. None of them is the operating leverage the price requires, and that leverage begins, or does not, in the quarter management has now staked to it.

What to Watch

The near-term calendar is three dated events and one running theme, in the order they land.

Late July 2026 — the fiscal 2026 Form 10-K. The first full filing. It carries the cash-flow statement, capital expenditure, and free cash flow the fourth-quarter release deferred, which turns the reverse-DCF base from a normalised estimate into a reported figure. It also carries the definitive Item 1A risk factors and the updated material-cash-requirements table, including whether the endorsement and product-purchase obligations moved with the classic-franchise reduction.

Late September 2026 — first-quarter FY2027 results. The guided margin inflection. Management pulled the first quarter of gross-margin expansion forward to this period and framed it as the last quarter of material year-over-year tariff pressure. The first-half revenue guide is down low to mid single digits. The test is not the revenue line, which management has already guided lower, but whether gross margin expands year-over-year as promised. That is the operating recovery the price embeds, arriving or not.

16-17 November 2026 — Investor Day. Management deferred the full-year FY2027 and multi-year outlook to this event, framing it as the next phase of the growth strategy. It resets the framework the primer is written against and is the natural anchor for the fiscal-year restatement. David Denton, in his first months as chief financial officer, presents the multi-year framework he inherited rather than set.

Ongoing — Greater China and the tariff step. Whether Greater China profitability bottoms as guided, and whether the locally created product arriving in holiday 2027 moves the revenue trajectory. On tariffs, whether the step to 15% after July holds and whether the first quarter of FY2027 proves the last material year-over-year headwind.

A refund carried FY2026. The margin recovery it substitutes for has to arrive in FY2027, and the chief financial officer who guided that recovery leaves in August.

Source: NIKE fiscal 2026 fourth-quarter and full-year results, earnings-call transcript, and prepared remarks, reported 30 June 2026, via Marvin Labs. CFO transition and successor appointment per Nike press release, 23 June 2026. Prior-period comparatives from NIKE FY2025 results. Peer data from Lululemon (fiscal year ended 1 February 2026), Adidas (FY2025), and On Holding (FY2025) company filings via Marvin Labs. The fiscal 2026 Form 10-K, which finalises cash flow and Item 1A risk factors, is expected late July 2026.